RESUMEN

Formamidinium (FA)-based 2D perovskites have emerged as highly promising candidates in solar cells. However, the insertion of 2D spacer cations into the perovskite lattice concomitantly introduces microstrain and unfavorable orientations that hinder efficiency and stability. In this study, by finely tuning the FA-based 2D perovskite lattice through spacer cation engineering, a stable lattice structure with balanced distortion, microstrain relaxation, and reduced carrier-lattice interactions is achieved. These advancements effectively stabilize the inherently soft lattice against light and thermal-aging stress. To reduce the photocurrent loss induced by undesired crystal texture, a polarity-matched molecular-type selenourea (SENA) additive is further employed to modulate the crystallization kinetics. The introduction of the SENA significantly inhibits the disordered crystallization induced by spacer cations and drives the templated growth of the quantum well structure with a vertical orientation. This controlled crystallization process effectively reduces crystal defects and enhances charge separation. Ultimately, the optimized FA-based perovskite photovoltaic devices achieve a remarkable power conversion efficiency (PCE) of 20.03% (certified steady-state efficiency of 19.30%), setting a new record for low-n 2D perovskite solar cells. Furthermore, the devices exhibit less than 1% efficiency degradation after operating at maximum power point for 1000 h and maintain excellent stability after thermal aging and cycles of cold-warm shock, respectively.

RESUMEN

Herein, eight new NHC-based selenourea derivatives were synthesized and characterized by using spectroscopic method (1H, 19F, and 13C NMR, FT-IR), and elemental analysis techniques. These compounds were synthesized by mixing benzimidazolium salts, potassium carbonate, and selenium powder in ethyl alcohol. Additionally, the molecular and crystal structures of the three compounds (1c, 2b, and 2c) were determined using the single-crystal x-ray diffraction (XRD) method. Diffraction analysis demonstrated the partial carbon-selenium double-bond character of these compounds. All compounds were determined to be highly potent inhibitors for AChE and XO enzymes. The IC50 values for the compounds were found in the range of 0.361-0.754 µM for XO and from 0.995 to 1.746 µM for AChE. The DNA binding properties of the compounds were investigated. These compounds did not have a remarkable DNA binding property. Also, DPPH radical scavenging activities of the compounds were also investigated. Compounds (1c), (2a), (3a), and (3b) exhibited more pronounced DPPH radical scavenging activity when compared to other compounds. Docking studies were applied by using AutoDock 4 to determine interaction mechanism of the selected compounds (1a), (1b), and (3b). The compound (1b) has good binding affinity (-9.78 kcal/mol) against AChE, and (-6.86 kcal/mol) for XO target. Drug similarity properties of these compounds compared to positive controls were estimated and evaluated by ADMET analysis. Furthermore, molecular dynamics simulations have been applied to understand the accuracy of docking studies. These findings and the defined compounds could be potential candidates for the discovery and progress of effective medicine(s) for AChE and XO in the future.Communicated by Ramaswamy H. Sarma.

Asunto(s)

Compuestos de Selenio , Selenio , Acetilcolinesterasa , Xantina Oxidasa , Rayos X , Espectroscopía Infrarroja por Transformada de Fourier , ADN , Simulación del Acoplamiento Molecular , Relación Estructura-Actividad , Estructura Molecular

RESUMEN

The inhibitory potency of the series of inhibitors of the soluble epoxide hydrolase (sEH) based on the selenourea moiety and containing adamantane and aromatic lipophilic groups ranges from 34.3 nM to 1.2 µM. The most active compound 5d possesses aliphatic spacers between the selenourea group and lipophilic fragments. Synthesized compounds were tested against the LPS-induced activation of primary murine macrophages. The most prominent anti-inflammatory activity, defined as a suppression of nitric oxide synthesis by LPS-stimulated macrophages, was demonstrated for compounds 4a and 5b. The cytotoxicity of the obtained substances was studied using human neuroblastoma and fibroblast cell cultures. Using these cell assays, the cytotoxic concentration for 4a was 4.7-18.4 times higher than the effective anti-inflammatory concentration. The genotoxicity and the ability to induce oxidative stress was studied using bacterial lux-biosensors. Substance 4a does not exhibit genotoxic properties, but it can cause oxidative stress at concentrations above 50 µM. Put together, the data showed the efficacy and safety of compound 4a.

Asunto(s)

Adamantano , Epóxido Hidrolasas , Adamantano/farmacología , Animales , Antiinflamatorios/farmacología , Inhibidores Enzimáticos/farmacología , Humanos , Lipopolisacáridos/farmacología , Ratones , Óxido Nítrico , Compuestos de Organoselenio , Urea/análogos & derivados

RESUMEN

We introduce a novel selenium-based compound [N-(Phenylcarbamoselenoyl) furan-2-carboxamide] for the optical and fluorimetric detection of Hg in an aqueous medium. The synthesized compound was characterized by different spectroscopic methods. The designed chemosensor FSU has shown a significant fluorescence quenching when Hg2+ ions were added to the sensing medium. Furthermore, Hg2+ ions provoked a 2:1 complex formation with the chemosensor FSU. It is found that the compound offers high selectivity over a variety of cations such as Co2+, Cr3+, Ni2+, Zn2+, Cu2+, Mg2+, Hg2+, Cd2+, Ca2+, Mn2+, Ga3+, Pb2+, Na+, Fe2+ and K+. The detection limit was calculated as 7.35 × 10-7 M. Also, FSU shows appreciable binding affinity towards Hg2+ ions with a binding constant value of 1.413 × 103 M-1. The ICT mechanism of mercury sensing was confirmed with spectroscopic techniques and DFT studies. Density functional theory was also implemented to investigate the structure of the Hg2+ complex and its electronic distribution in the aqueous medium. Finally, an MEP study was also carried out to obtain detailed information about the surface characteristics of the chemosensor FSU. Effectively, we have reported a potent chemosensor for Hg2+ in the aqueous medium.

Asunto(s)

Mercurio , Selenio , Espectrometría de Fluorescencia/métodos , Cadmio , Plomo , Mercurio/química , Agua , Cationes , Modelos Teóricos , Furanos , Colorantes Fluorescentes/química

RESUMEN

In this study, we report on the synthesis of new organoselenium derivatives, including nonsteroidal anti-inflammatory drugs (NSAIDs) scaffolds and Se functionalities (isoselenocyanate and selenourea), which were evaluated against four types of cancer cell line: SW480 (human colon adenocarcinoma cells), HeLa (human cervical cancer cells), A549 (human lung carcinoma cells), MCF-7 (human breast adenocarcinoma cells). Among these compounds, most of the investigated compounds reduced the viability of different cancer cell lines. The most promising compound 6b showed IC50 values under 10 µM against the four cancer cell lines, particularly to HeLa and MCF-7, with IC50 values of 2.3 and 2.5 µM, respectively. Furthermore, two compounds, 6b and 6f, were selected to investigate their ability to induce apoptosis in MCF-7 cells via modulation of the expression of anti-apoptotic Bcl-2 protein, pro-inflammatory cytokines (IL-2) and proapoptotic caspase-3 protein. The redox properties of the NSAIDs-Se derivatives were conducted by 2, 2-didiphenyl-1-picrylhydrazyl (DPPH), bleomycin-dependent DNA damage and glutathione peroxidase (GPx)-like assays. Finally, a molecular docking study revealed that an interaction with the active site of thioredoxin reductase 1 (TrxR1) predicted the antiproliferative activity of the synthesized candidates. Overall, these results could serve as a promising launch point for further designs of NSAIDs-Se derivatives as potential antiproliferative agents.

Asunto(s)

Adenocarcinoma , Antineoplásicos , Neoplasias del Colon , Antiinflamatorios no Esteroideos/farmacología , Antineoplásicos/química , Apoptosis , Línea Celular Tumoral , Proliferación Celular , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Simulación del Acoplamiento Molecular , Estructura Molecular , Compuestos de Organoselenio , Relación Estructura-Actividad , Urea/análogos & derivados

RESUMEN

A series of chiral and achiral cyclic seleno- and thiourea compounds bearing benzyl groups on N-atoms were prepared from enetetramines and appropriate Group VI elements in good yields. All the synthesized compounds were characterized by elemental analysis, FT-IR, 1H NMR and 13C NMR spectroscopy, and the molecular and crystal structures of (R,R)-4b and (R,R)-5b were confirmed by the single-crystal X-ray diffraction method. These assayed for their activities against metabolic enzymes acetylcholinesterase, butyrylcholinesterase, and α-glycosidase. These selenourea and thiourea derivatives of chiral and achiral enetetramines effectively inhibit AChE and BChE with IC50 values in the range of 3.32-11.36 and 1.47-9.73 µM, respectively. Also, these compounds inhibited α-glycosidase enzyme with IC50 values varying between 1.37 and 8.53 µM. The results indicated that all the synthesized compounds exhibited excellent inhibitory activities against mentioned enzymes as compared with standard inhibitors. Representatively, the most potent compound against α-glycosidase enzyme, (S,S)-5b, was 12-times more potent than standard inhibitor acarbose; 7b and 8a as most potent compounds against cholinesterase enzymes, were around 5 and 13-times more potent than standard inhibitor tacrine against achethylcholinesterase (AChE) and butyrylcholinesterase (BChE), respectively.

Asunto(s)

Acetilcolinesterasa , Butirilcolinesterasa , Acetilcolinesterasa/metabolismo , Butirilcolinesterasa/metabolismo , Inhibidores de la Colinesterasa/química , Glicósido Hidrolasas/metabolismo , Simulación del Acoplamiento Molecular , Estructura Molecular , Compuestos de Organoselenio , Espectroscopía Infrarroja por Transformada de Fourier , Relación Estructura-Actividad , Tiourea/farmacología , Urea/análogos & derivados

RESUMEN

Selenium containing drugs like selenomethionine, selenocystine, selenourea and methylseleninic acid are reported to exhibit potential anticancer effect. However, these anticancer drugs may exert adverse effects when used over a prolonged period. Little is known about the interaction of these selenium containing drugs with the vital erythroid protein hemoglobin. In this work a comparative study of the interaction of organo-selenium drugs with hemoglobin and heme moiety has been performed using different spectroscopic techniques to find out their role on drug induced methemoglobinemia. We found that though these selenium containing drugs have similar binding affinity towards hemoglobin, they have differential interactions with the heme group. Isothermal calorimetric titration study showed that selenourea has the lowest binding affinity (Kd 19.28 µM) towards HbA as compared to other drugs, selenomethionine, selenocystine and methylseleninic acid (Kd 7.69 µM, 4.88 µM and 10.5 µM at 37 °C respectively). This result is also supported by the molecular docking study. Methylseleninic acid was found to have detrimental effects on nitrite induced methemoglobinemia, a hematological disorder caused due to excessive conversion of Fe2+ to Fe3+ in hemoglobin. Hence the results of the study would help to develop a better insight on the mechanism of action and anticipate the toxicity of these drugs which require further optimization before their actual use in the treatment of cancer.

Asunto(s)

Antineoplásicos , Metahemoglobinemia , Compuestos de Organoselenio , Selenio , Humanos , Metahemoglobinemia/inducido químicamente , Metahemoglobinemia/tratamiento farmacológico , Simulación del Acoplamiento Molecular , Nitritos , Compuestos de Organoselenio/toxicidad

RESUMEN

A sequence of aroyl selenourea ligands (L1-L3) substituted by aniline and their Ru(II) (η6-p-cymene) complexes (1-3), [Ru(II) (η6-p-cymene) L] (L = monodentate aroyl selenourea ligand) have been synthesized and characterized the composition of the ligands and their metal complexes. The molecular structures of ligand L1 and complex 3 were also confirmed by single XRD crystal method. The single-crystal XRD study showed that aroyl selenourea ligand coordinates with Ru via Se novel neutral monodentate atom. In vitro DNA interaction studies were investigated by Fluorescence and UV-Visible spectroscopic methods which showed that the intercalative mode of binding is in the order of 1 > 2 > 3 with Ru(II) (η6-p-cymene) complexes. Spectroscopic methods have been used for measuring the binding affinity of bovine serum albumin to complex. Moreover, the cytotoxic study of complexes (1-3) were evaluated against HeLa S3, A549, and IMR90 cells, resulting in complexes 1 and 2 showed promising cytotoxic activity against HeLa S3 cell with IC50 values of 24 and 26 µM, respectively. Also, the morphological changes of HeLa S3 and A549 cells were confirmed by fluorescence microscope in the presence of complexes 1 and 2 using AO (acridine orange, 200 µM) and EB (ethidium bromide, 100 µM). In addition, the docking results strongly support the protein binding studies of the complexes.Communicated by Ramaswamy H. Sarma.

Asunto(s)

Antineoplásicos , Complejos de Coordinación , Rutenio , Compuestos de Anilina , Antineoplásicos/farmacología , Línea Celular Tumoral , Complejos de Coordinación/farmacología , Cimenos , Humanos , Simulación del Acoplamiento Molecular , Estructura Molecular , Compuestos de Organoselenio , Urea/análogos & derivados

RESUMEN

Organoselenium drugs like selenourea (SeU) and selenocystine (SeC) are found to exhibit several medicinal properties and have reported roles in the field of cancer prevention. However, studies related to their interactions with the major erythroid protein, haemoglobin (HbA) are still in dearth despite being of prime importance. In view of this, it was considered essential to investigate the interaction of these two anticancer drugs with Hb. Both the drugs showed significant changes in absorption spectra of Hb at wavelength of maximum absorption (λmax) 630 nm. SeU itself had no effect on the absorbance value at 630 nm with respect to time even with 400 µM concentration. However, it was rapidly converted to nanoselenium in presence of nitrite and there was an increase in the absorbance rate at 630 nm from 3.39 × 10-3 min-1 (without nitrite) to 8.94 × 10-3 min-1 in presence of nitrite (200 µM) owing to the generation of reactive oxygen species in the medium. Although the generation and increase in peak intensity at 630 nm in Hb generally indicates the formation and rise in the levels of methaemoglobin (metHb), nanoselenium was observed to follow a different path. Instead of causing oxidation of Fe2+ to Fe3+ responsible for metHb formation, nanoselenium was found to interact with the protein part, thereby causing changes in its secondary structure which is reflected in the increasing absorbance at 630 nm. SeC, however, showed a different effect. It was shown to act as a novel agent to reduce nitrite-induced metHb formation in a dose-dependent manner. The efficiency of SeC was again found to be less in diabetic blood samples as compared to the non-diabetic ones. For similar ratio of metHb to SeC (1:8), % reduction of metHb was found to be 27.46 ± 0.82 and 16.1 ± 2.4 for non-diabetic and diabetic samples, respectively, with a two tailed P-value much <0.05 which implies that the data are highly significant.

Asunto(s)

Cistina/análogos & derivados , Diabetes Mellitus/sangre , Hemoglobinas/metabolismo , Metahemoglobinemia/sangre , Compuestos de Organoselenio/farmacología , Urea/análogos & derivados , Anciano , Cistina/metabolismo , Cistina/farmacología , Diabetes Mellitus/metabolismo , Hemoglobinas/análisis , Humanos , Metahemoglobina/análisis , Metahemoglobina/metabolismo , Metahemoglobinemia/metabolismo , Persona de Mediana Edad , Nitritos/sangre , Compuestos de Organoselenio/metabolismo , Oxidación-Reducción , Especies Reactivas de Oxígeno , Urea/metabolismo , Urea/farmacología

RESUMEN

Dietary selenium deficiency is recognized as a global problem. Pork is the most widely consumed meat throughout the world and an important source of selenium for humans. In this study, a reliable approach was developed for analyzing selenium and its speciation in the muscles of pigs after different selenium treatments. The selenium source deposition efficiency was ranked as: selenomethionine > methylselenocysteine > selenite, and the muscle selenium content had a dose effect with selenomethionine supplementation. In total, four species of selenium were detected in the muscles of pigs and the distributions of these selenium species were greatly affected by the dietary selenium supplementation forms and levels. Selenomethionine (>70% of total selenium) and selenocystine (>11%) were the major selenium species, followed by methylselenocysteine and selenourea. Therefore, selenium-enriched pork produced from selenomethionine is a good source for improving human dietary selenium intake.

Asunto(s)

Cromatografía Líquida de Alta Presión/métodos , Espectrometría de Masas/métodos , Músculo Esquelético/química , Compuestos de Selenio/farmacología , Selenio/análisis , Animales , Cistina/análogos & derivados , Cistina/análisis , Suplementos Dietéticos , Análisis de los Alimentos/métodos , Masculino , Músculo Esquelético/efectos de los fármacos , Compuestos de Organoselenio/análisis , Reproducibilidad de los Resultados , Ácido Selenioso/farmacología , Compuestos de Selenio/análisis , Selenocisteína/análogos & derivados , Selenocisteína/farmacología , Selenometionina/análisis , Selenometionina/farmacología , Porcinos , Urea/análogos & derivados , Urea/análisis

RESUMEN

A novel series of thirty-one N-substituted urea, thiourea, and selenourea derivatives containing diphenyldiselenide entities were synthesized, fully characterized by spectroscopic and analytical methods, and screened for their in vitro leishmanicidal activities. The cytotoxic activity of these derivatives was tested against Leishmania infantum axenic amastigotes, and selectivity was assessed in human THP-1 cells. Thirteen of the synthesized compounds showed a significant antileishmanial activity, with 50% effective concentration (EC50) values lower than that for the reference drug miltefosine (EC50, 2.84 µM). In addition, the derivatives 9, 11, 42, and 47, with EC50 between 1.1 and 1.95 µM, also displayed excellent selectivity (selectivity index ranged from 12.4 to 22.7) and were tested against infected macrophages. Compound 11, a derivative with a cyclohexyl chain, exhibited the highest activity against intracellular amastigotes, with EC50 values similar to those observed for the standard drug edelfosine. Structure-activity relationship analyses revealed that N-aliphatic substitution in urea and selenourea is recommended for the leishmanicidal activity of these analogs. Preliminary studies of the mechanism of action for the hit compounds was carried out by measuring their ability to inhibit trypanothione reductase. Even though the obtained results suggest that this enzyme is not the target for most of these derivatives, their activity comparable to that of the standards and lack of toxicity in THP-1 cells highlight the potential of these compounds to be optimized for leishmaniasis treatment.

Asunto(s)

Antiprotozoarios/síntesis química , Antiprotozoarios/uso terapéutico , Leishmania infantum/efectos de los fármacos , Compuestos de Organoselenio/química , Tiourea/química , Urea/análogos & derivados , Urea/química , Antiprotozoarios/química , Humanos , Leishmania infantum/patogenicidad , Macrófagos/parasitología , NADH NADPH Oxidorreductasas/metabolismo , Pruebas de Sensibilidad Parasitaria , Relación Estructura-Actividad

RESUMEN

Four new acyclic diaminocarbenes (ADACs), viz. [(cyclo-Cn H2n-1 )2 N]2 C (n=5-7) and iPr2 N-C-N(cyclo-C6 H11 )2 , were synthesised by reacting the corresponding formamidinium hexafluorophosphates with NaN(SiMe3 )2 . Their nucleophilicities and electrophilicities were respectively judged from the 1 JCH values determined for the N2 CH unit of the corresponding formamidinium cations and from the 77 Se NMR chemical shifts of the selenourea derivatives obtained from the reaction of elemental selenium with the corresponding ADACs. An ambiphilic profile essentially identical to that of the "Alder carbene" (iPr2 N)2 C was found in each case. Similar to the latter carbene, the new ADACs undergo a well-defined thermal decomposition by ß-fragmentation, affording an alkene and a formamidine. The stabilities of [(cyclo-Cn H2n-1 )2 N]2 C depend strongly on the value of n, following the order 6>5>7, with the latter congener being too unstable for isolation. [(cyclo-C6 H11 )2 N]2 C shows no thermal decomposition at room temperature in solution and is thus significantly more stable than (iPr2 N)2 C. The stability of iPr2 N-C-N(cyclo-C6 H11 )2 is intermediate between that of (iPr2 N)2 C and [(cyclo-C6 H11 )2 N]2 C, its ß-fragmentation selectively affording propene and iPrN=CH-N(cyclo-C6 H11 )2 . [(cyclo-Cn H2n-1 )2 N]2 C (n=5-7) react readily with CO under mild conditions, selectively affording trisubstituted spirocyclic ß-lactam derivatives with an antimicrobial activity spectrum similar to that of penicillin G.

RESUMEN

Synthesis and anti-melanoma activity of novel naphthalimide isoselenocyanate (NISC) and naphthalimide selenourea (NSU) analogs are described. The novel agents were screened for growth inhibition of different human melanoma cell lines including those having BRAFV600E mutation (UACC903, 1205Lu, and A375M) and BRAFWT (CHL-1). In general, the NISC analogs (4a-d) were more effective in inhibiting the cell viability than the NSU analogs (7a-b). Overall, NISC-6 (4d), having a six-carbon alkyl chain, was identified as the most cytotoxic compound in both BRAFV600E mutated and BRAFWT cells. NISC-6 docked strongly into the binding sites of Akt1 and human topoisomerase IIα (Topo-IIα), and the docking results were supported by experimental findings showing NISC-6 to inhibit of both Akt pathway and Topo-IIα activity in a dose dependent manner. Furthermore, NISC-6 effectively induced apoptosis in human melanoma cells, inhibited tumor growth by ∼69% in a melanoma mouse xenograft model, and showed excellent compliance with the Lipinski' rule of five, suggesting both its efficacy and drug-like behavior under physiological conditions.

Asunto(s)

Antineoplásicos/farmacología , Proteínas de Unión al ADN/antagonistas & inhibidores , Diseño de Fármacos , Inhibidores Enzimáticos/farmacología , Melanoma/tratamiento farmacológico , Naftalenos/farmacología , Nitrilos/farmacología , Proteínas Proto-Oncogénicas c-akt/antagonistas & inhibidores , Antígenos de Neoplasias/metabolismo , Antineoplásicos/síntesis química , Antineoplásicos/química , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , ADN-Topoisomerasas de Tipo II/metabolismo , Proteínas de Unión al ADN/metabolismo , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/química , Humanos , Melanoma/patología , Estructura Molecular , Naftalenos/síntesis química , Naftalenos/química , Nitrilos/síntesis química , Nitrilos/química , Proteínas Proto-Oncogénicas c-akt/metabolismo , Relación Estructura-Actividad

RESUMEN

A series of novel selenourea derivatives and corresponding thiourea analogs were synthesized and tested against a panel of six human cancer cell lines: melanoma (1205Lu), lung carcinoma (A549), prostatic carcinoma (DU145), colorectal carcinoma (HCT116), pancreatic epithelioid carcinoma (PANC-1) and pancreatic adenocarcinoma (BxPC3). In general, we found that the selenium-containing derivatives were more potent than their isosteric sulfur analogs. Four selenourea derivatives (1e, 1f, 1g and 1i) showed IC50 values below 10 µM in all of tested cell lines at 72 h. On the basis of its potent activity, compound 1g was selected for further biological evaluation in different colon cancer cell lines. Our results indicated that compound 1g induced apoptosis by caspase activation, along with inhibition of anti-apoptotic proteins.

Asunto(s)

Antineoplásicos/farmacología , Compuestos de Organoselenio/farmacología , Tiourea/farmacología , Urea/análogos & derivados , Antineoplásicos/síntesis química , Antineoplásicos/química , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Humanos , Estructura Molecular , Compuestos de Organoselenio/síntesis química , Compuestos de Organoselenio/química , Relación Estructura-Actividad , Tiourea/síntesis química , Tiourea/química , Células Tumorales Cultivadas , Urea/síntesis química , Urea/química , Urea/farmacología

RESUMEN

Analysis of antioxidant activity of synthesized selenourea derivatives showed that N,N'-substituted selenoureas inhibited Fe(III)-induced LPO in rat brain homogenate. On the other hand, oxygen- and sulfur-containing analogs exhibited no antioxidant activity or even slight prooxidant activity. Intramolecular alkylation of selenium atom also led to loss of antioxidant activity. Thus, antioxidant activity of the compounds was due to the presence of a nonalkylated selenium atom in N,N'-substituted selenourea analogs.

Asunto(s)

Antioxidantes/farmacología , Compuestos Férricos/farmacología , Compuestos de Organoselenio/farmacología , Urea/análogos & derivados , Animales , Peroxidación de Lípido/efectos de los fármacos , Oxidación-Reducción/efectos de los fármacos , Ratas , Especies Reactivas de Oxígeno/metabolismo , Urea/farmacología